<div id="readability-page-1"><div>By Adria Calatayud Germany's Merck KGaA reported higher earnings and sales for the third quarter, helped by organic growth across its three businesses, and narrowed its outlook for the full year. The life-sciences and chemicals group said Thursday that it made an after-tax profit of 898 million euros ($1.04 billion) for the third quarter compared with 812 million euros for the year-earlier period. Excluding exceptional items, the company's earnings before interest, taxes, depreciation and amortization--its preferred profit metric--were 1.67 billion euros, up 3.1% on year and up 8.8% organically. Net sales grew 5.2% organically to 5.32 billion euros. The company said solid organic growth across all sectors contributed to its performance, particularly driven by demand for pharma-production products in its life-sciences segment, rare diseases treatments in its healthcare business and semiconductor materials in its electronics unit. Analysts had forecast third-quarter Ebitda before exceptional items of 1.56 billion euros on net sales of 5.23 billion euros, according to consensus estimates compiled by Vara Research. For the full year, Merck confirmed its outlook, narrowing its guidance ranges but leaving the midpoints unchanged. It now expects organic sales growth of about 3% in sales and of 5% to 7% in Ebitda before exceptional items, which compares with prior forecasts of organic sales growth of 2% to 5% and of Ebitda before exceptional items increasing by 4% to 8% organically. Write to Adria Calatayud at adria.calatayud@wsj.com (END) Dow Jones Newswires11-13-25 0124ET</div></div>

德国默克

德国默克（Merck KGaA）报告第三季度净销售额实现 5.2% 的有机增长，达到 53.2 亿欧元，税后利润为 8.98 亿欧元。该公司的息税折旧摊销前利润（EBITDA）在剔除特殊项目后上升至 16.7 亿欧元，超出分析师预期。默克已缩小 2025 年的展望，预计有机销售增长约为 3%，EBITDA 增长为 5%-7%。指导中点保持不变，预计 2025 年的销售额在 208 亿欧元至 214 亿欧元之间

德国默克 KGaA 因各部门的有机增长实现了更高的收益